Dr. Agarwals Health Care Ltd

Dr. Agarwals Health Care Ltd. has dispatched letters with a direct web-link and QR code to access meeting notices and documents for Equity Shareholders, Secured Creditors, and Unsecured Creditors. These meetings are convened as per the National Company Law Tribunal, Chennai Bench directions. The letters were sent to shareholders and creditors whose email addresses are not registered with the company.

Dr. Agarwals Health Care Ltd's wholly-owned subsidiary, Orbit Healthcare Services (Mauritius) Limited, has completed an investment of USD 200,000 in Orbit Health Care ETH PLC. This investment makes Orbit Health Care ETH PLC a wholly-owned subsidiary of Orbit Healthcare Services (Mauritius) Limited and an indirect/step-down wholly-owned subsidiary of Dr. Agarwal’s Health Care Limited.

Dr. Agarwals Health Care Ltd received a Show Cause Notice (SCN) from GST authorities alleging discrepancies in FY24 returns. The SCN demands a response within 30 days regarding GST, interest, and penalties amounting to ₹20.5 Crores. The company is evaluating the SCN and plans to respond appropriately, but does not anticipate a significant impact on its financials or operations.

Dr. Agarwals Health Care Ltd announced its audited consolidated financial results for the quarter and year ended March 31, 2026. FY2026 total income soared by 20.9% YoY to ₹2,125 Crores, with IND-AS EBITDA growing by 22.2% YoY to ₹614 Crores and PAT growing by 52.4% YoY to ₹168 Crores. The company's network expanded to 288 facilities, adding 19 new centers during the quarter. The board also approved the reallocation of unspent 'Issue Related Expenses' to 'General Corporate Purposes and Unidentified Inorganic Acquisitions'.

Dr. Agarwals Health Care Ltd announced its audited consolidated financial results for FY26. Total income soared by 20.9% YoY to ₹2,125 crores, while IND-AS EBITDA grew by 22.2% YoY to ₹614 crores. The company's PAT increased by 52.4% YoY to ₹168 crores. The board also approved the reallocation of unspent 'Issue Related Expenses' to 'General Corporate Purposes and Unidentified Inorganic Acquisitions'. As of March 31, 2026, the company's network includes 288 facilities, with 19 new centers added during the quarter.

Dr. Agarwals Health Care Ltd has received a Show Cause Notice (SCN) from GST authorities for alleged discrepancies in FY2023-24 returns, potentially involving ₹20.5 Crores in GST, interest, and penalties. The company is examining the SCN and will respond within the stipulated time, but does not anticipate a significant impact on its financials or operations.

Dr. Agarwal's Health Care Limited's monitoring agency report for the quarter ended March 31, 2026, issued by ICRA Limited on May 15, 2026, indicates that the utilization of IPO proceeds is in line with the objects of the issue. There were no deviations observed. The report, as per Regulation 32(6) of SEBI guidelines, confirms an objective view of the utilization of issue proceeds based on information provided by the issuer. The IPO size was ₹3,027.260 Crore, with ₹300 Crore excluding the OFS portion.

Dr. Agarwals Health Care Ltd received a Show Cause Notice (SCN) from GST authorities alleging discrepancies in FY23 returns. The notice, dated May 14, 2026, from the Assistant Commissioner, GST & Central Excise, Nungambakkam, Chennai, claims discrepancies such as output turnover differences, short tax payments, and ineligible ITC claims. The company is required to respond within 30 days, potentially facing a GST demand of ₹15.08 Crores plus interest and penalties. The company is examining the notice and does not anticipate a significant impact on its financials or operations.

Dr. Agarwals Health Care Ltd has scheduled a Board of Directors meeting on May 21, 2026, to consider and approve the Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2026. An earnings/analyst conference call will be hosted on the same day post the board meeting. The trading window remains closed until 48 hours after the announcement of the Financial Results.

Dr. Agarwals Health Care Ltd. announced that the Hon'ble NCLT, Chennai Bench, has approved the Scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited. The order, dated May 05, 2026, directs the convening of shareholder and creditor meetings on July 02, 2026, to consider the proposed amalgamation. The company is awaiting the certified copy of the order, which will be made available on its website. The scheme is subject to necessary statutory and regulatory approvals.